Clinical Trials Market Growing at 6.51% CAGR to 2030 Driven by Hybrid and Decentralized Trial Adoption | Mordor Intelligence Forecast

Rising Adoption of Decentralized and Hybrid Trial Models Rising Adoption of Decentralized and Hybrid Trial Models Decentralized and hybrid trial models are transforming clinical research by reducing patient travel, improving retention, and expanding access through telehealth, local labs, and at-home monitoring. With growing acceptance among participants and clear regulatory guidance from the FDA, sponsors are focusing on technology readiness, data integrity, and cybersecurity as key...

HYDERABAD, India, 28/10/2025 (informazione.news - comunicati stampa - salute e benessere)

Decentralized and hybrid trial models are transforming clinical research by reducing patient travel, improving retention, and expanding access through telehealth, local labs, and at-home monitoring. With growing acceptance among participants and clear regulatory guidance from the FDA, sponsors are focusing on technology readiness, data integrity, and cybersecurity as key priorities. This shift is also driving greater investment in digital platforms and reshaping how CROs deliver trial operations.

Sponsors increasingly use predictive analytics, AI-driven patient matching, and real-time trial monitoring to optimize enrollment, minimize delays, and improve protocol adherence.

North America continues to hold a commanding position in the clinical trials market, backed by robust pharma-biotech investment, mature regulatory frameworks, and a dense network of CRO and site infrastructure. Meanwhile, the Asia-Pacific region is emerging as the fastest-growing market, driven by expanding treatment-naïve populations, rising clinical-research capacity in China and India , and the growing appeal of cost-efficient, hybrid trial models in emerging geographies.

The clinical trials market is moderately fragmented, with global CROs and service providers actively integrating digital-trial platforms, real-world-evidence modules, and decentralized capabilities into their portfolios. Strategic mergers, acquisitions, and long-term master services agreements are typical to secure end-to-end trial support.

 

The Virtual Clinical Trials Market Report is Segmented by Study Design (Interventional), Phase (Phase I, Component (Software Platforms and Services), Delivery Mode (Web-Based), End User (Medical-Device Manufacturers), Indication (Oncology), Geography ( North America , Europe , Asia-Pacific ).

Medable, IQVIA, Parexel International Corp, Labcorp (Covance) and ICON are the major companies operating in this market.

The Decentralized Clinical Trials Market Report is Segmented by Study Design (Interventional), Component (Cloud-Based Platforms), Therapeutic Application (Oncology, Cardiology), End-User (Pharmaceutical & Biotech Sponsors), Geography ( North America , Europe , Asia-Pacific , The Middle East and Africa , and South America ).

The Clinical Trial Support Services Market Report is Segmented by Phase (Phase I, Phase II), Service Types (Clinical Trial Site Management, Patient Recruitment & Retention), End User (Pharmaceutical Companies, Biotechnology Companies), Therapeutic Area (Oncology, Cardiology), and Geography ( North America , Europe ).

Roche, Eli Lilly and Company, Novo Nordisk, IQVIA and LabCorp are the major companies operating in this market.

Mordor Intelligence is a trusted partner for businesses seeking comprehensive and actionable market intelligence. Our global reach, expert team, and tailored solutions empower organizations and individuals to make informed decisions, navigate complex markets, and achieve their strategic goals. 

With a team of over 550 domain experts and on-ground specialists spanning 150+ countries, Mordor Intelligence possesses a unique understanding of the global business landscape. This expertise translates into comprehensive syndicated and custom research reports covering a wide spectrum of industries, including aerospace & defense, agriculture, animal nutrition and wellness, automation, automotive, chemicals & materials, consumer goods & services, electronics, energy & power, financial services, food & beverages, healthcare, hospitality & tourism, information & communications technology, investment opportunities, and logistics. 

media@mordorintelligence.com
https://www.mordorintelligence.com/contact-us

Logo: https://mma.prnewswire.com/media/2746908/Mordor_Intelligence_Logo.jpg

 

View original content:https://www.prnewswire.co.uk/news-releases/clinical-trials-market-growing-at-6-51-cagr-to-2030-driven-by-hybrid-and-decentralized-trial-adoption--mordor-intelligence-forecast-302596465.html